Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan

Vaccine

Volumn 30, Issue 27, 2012, Pages 4034-4039

  Su, Fu Hsiung ^a,b   Bai, Chyi Huey ^a   Chu, Fang Yeh ^c   Lin, Yu Shiang ^a,c   Su, Chien Tien ^a,b   Yeh, Chih Ching ^a,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Booster; HBV; HBV serology; Isolated anti HBc; Vaccination

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; BOOSTER VACCINATION; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; HEPATITIS B; HUMAN; INFANCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING; SEROPREVALENCE; TAIWAN; UNIVERSITY STUDENT; VACCINATION;

FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INFANT; INFANT, NEWBORN; MALE; TAIWAN; VACCINATION; YOUNG ADULT;

EID: 84861478694     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.031     Document Type: Article

References (40)

1. Knoll A., Hartmann A., Hamoshi H., Weislmaier K., Jilg W. Serological pattern " anti-HBc alone" : characterization of 552 individuals and clinical significance. World Journal of Gastroenterology 2006, 12:1255-1260.
2. World Health Organization. WHO position paper on hepatitis B vaccines No. 40. Geneva, WHO, 2009. [Accessed February 2012]. http://www.who.int/wer/2009/wer8440.pdf.
3. Ponde R.A., Cardoso D.D., Ferro M.O. The underlying mechanisms for the 'anti-HBc alone' serological profile. Archives of Virology 2010, 155:149-158.
4. Grob P., Jilg W., Bornhak H., Gerken G., Gerlich W., Gunther S., et al. Serological pattern " anti-HBc alone" : report on a workshop. Journal of Medical Virology 2000, 62:450-455.
5. Chan C.Y., Lee S.D., Tsai Y.T., Lo K.J., Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc. Journal of Gastroenterology and Hepatology 1995, 10:192-197.
6. Ural O., Findik D. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. Journal of Infection 2001, 43:187-190.
7. Silva A.E., McMahon B.J., Parkinson A.J., Sjogren M.H., Hoofnagle J.H., Di Bisceglie A.M., et al. virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clinical Infectious Diseases 1998, 26:895-897.
8. Lu C.Y., Chiang B.L., Chi W.K., Chang M.H., Ni Y.H., Hsu H.M., et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004, 40:1415-1420.
9. Lu S.N., Chen C.H., Chen T.M., Lee P.L., Wang J.H., Tung H.D., et al. virus infection in adolescents in a rural township -15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 2006, 24:759-765.
10. Zervou E.K., Dalekos G.N., Boumba D.S., Tsianos E.V. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion 2001, 41:652-658.
11. Allain J.P. Occult hepatitis B virus infection: implications in transfusion. Vox Sanguinis 2004, 86:83-91.
12. Chen H.L., Chang M.H., Ni Y.H., Hsu H.Y., Lee P.I., Lee C.Y., et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996, 276:906-908.
13. Tsen Y.J., Chang M.H., Hsu H.Y., Lee C.Y., Sung J.L., Chen D.S. Seroprevalence of hepatitis B virus infection in children in Taipei 1989 five years after a mass hepatitis B vaccination program. Journal of Medical Virology 1991, 34:96-99.
14. Chang M.H., Chen C.J., Lai M.S., Hsu H.M., Wu T.C., Kong M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children Taiwan Childhood Hepatoma Study Group. New England Journal of Medicine 1997, 336:1855-1859.
15. Ni Y.H., Chang M.H., Huang L.M., Chen H.L., Hsu H.Y., Chiu T.Y., et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Annals of Internal Medicine 2001, 135:796-800.
16. Lin H.H., Wang L.Y., Hu C.T., Huang S.C., Huang L.C., Lin S.S., et al. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. Journal of Medical Virology 2003, 69:471-474.
17. Su F.H., Chen J.D., Cheng S.H., Lin C.H., Liu Y.H., Chu F.Y. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program. Journal of Medical Virology 2007, 79:138-143.
18. Su F.H., Cheng S.H., Li C.Y., Chen J.D., Hsiao C.Y., Chien C.C., et al. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. Vaccine 2007, 25:8085-8090.
19. Su F.H., Chen J.D., Cheng S.H., Sung K.Y., Jeng J.J., Chu F.Y. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme. Journal of Viral Hepatitis 2008, 15:14-19.
20. Berger A., Doerr H.W., Rabenau H.F., Weber B. High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen. Intervirology 2000, 43:71-76.
21. Petersen K.M., Bulkow L.R., McMahon B.J., Zanis C., Getty M., Peters H., et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatric Infectious Disease Journal 2004, 23:650-655.
22. Jan C.F., Huang K.C., Chien Y.C., Greydanus D.E., Davies H.D., Chiu T.Y., et al. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology 2010, 51:1547-1554.
23. Wu J.S., Chen C.H., Chiang Y.H., Lee Y.C., Lee M.H., Ko Y.C., et al. Hepatitis B virus infection in Taiwan with reference to anti-HBc versus HBsAg and anti-HBs. Taiwan Yi Xue Hui Za Zhi 1980, 79:760-767.
24. Wang S.S., Yeh C.L., Tsai Y.T., Lee S.D., Lai K.H., Lo K.J. Occupational exposure to hepatitis B virus among hospital personnel. Taiwan Yi Xue Hui Za Zhi 1985, 84:810-816.
25. Kang S.Y., Kim M.H., Lee W.I. The prevalence of " anti-HBc alone" and HBV DNA detection among anti-HBc alone in Korea. Journal of Medical Virology 2010, 82:1508-1514.
26. Vitale F., Tramuto F., Orlando A., Vizzini G., Meli V., Cerame G., et al. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?. Journal of Medical Virology 2008, 80:577-582.
27. Hung C.C., Hsiao C.F. Isolated antibody to hepatitis B core antigen in individuals infected with HIV-1. Clinical Infectious Diseases 2003, 37:1275-1276.
28. Liang S.H., Chen T.J., Lee S.S., Tseng F.C., Huang C.K., Lai C.H., et al. Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection. Journal of Acquired Immune Deficiency Syndromes 2010, 54:122-128.
29. Neau D., Winnock M., Galperine T., Jouvencel A.C., Castera L., Legrand E., et al. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Medicine 2004, 5:171-173.
30. French A.L., Operskalski E., Peters M., Strickler H.D., Tien P.C., Sharp G.B., et al. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. Journal of Infectious Diseases 2007, 195:1437-1442.
31. Berger A., Preiser W., Doerr H.W. The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. Journal of Clinical Virology 2001, 20:23-30.
32. Greub G., Frei P.C. Isolated antibody to hepatitis B core is associated with hepatitis C virus co-infection. Clinical Microbiology and Infection 2000, 6:629.
33. Jilg W., Sieger E., Zachoval R., Schatzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. Journal of Hepatology 1995, 23:14-20.
34. Ramia S., Ramlawi F., Kanaan M., Klayme S., Naman R. Frequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donors. Epidemiology and Infection 2005, 133:695-699.
35. Gandhi R.T., Wurcel A., Lee H., McGovern B., Boczanowski M., Gerwin R., et al. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clinical Infectious Diseases 2003, 36:1602-1605.
36. Helmy A., Al-Sebayel M.I. Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection. World Journal of Gastroenterology 2006, 12:4406-4410.
37. Chen C.H., Yang P.M., Huang G.T., Lee H.S., Sung J.L., Sheu J.C. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. Journal of the Formosan Medical Association 2007, 106:148-155.
38. Centers for Disease Control, Taiwan, ROC. Statistics of HIV/AIDS 2011. http://www.cdc.gov.tw/np.asp%3FctNode=2231%26mp=5.
39. Weinberger K.M., Bauer T., Bohm S., Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. Journal of General Virology 2000, 81:1165-1174.
40. Lok A.S., Lai C.L., Wu P.C. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988, 8:766-770.